Spread the love

GBMD Chief-Scientist Dr Boominathan PhD reports that activation of p53/p63/p73-dependent biological pathway may inhibit HIV entry.  Furthermore, Dr Boominathan identifies mechanism through which p53/p63/p73 inhibits HIV entry. This study suggests that “p63/p73/p53 activators” may finds its use in inhibiting HIV entry.

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Activation of the p53/p63/p73 pathway inhibits HIV entry , 27/May/2013, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

* Research cooperation

Spread the love